InvestSMART

Racura Oncology Ltd (ASX:RAC)

ALERT: Price-sensitive ASX Announcement for RAC
Current share price for RAC : $1.990 -0.54 (-21.34%)+
Announcement
Release
28 May 2026 4:43PM
Price at Release
$2.530
Full Release
download
Summary
Racura Oncology Ltd has entered into an Underwriting Agreement with Dr AJ Robinson to underwrite any remaining unexercised $1.25 Piggyback Options as of the expiry date, 29 May 2026. As of the announcement, 1,838,524 options remain unexercised, but further conversions are anticipated. Funds raised will support Racura's clinical programs, including those in AML, lung cancer, and anthracycline cardioprotection. The underwriter is not a related party to the company, and the agreement involves no underwriting fee. The company aims to raise up to $2,298,155 through this initiative.
Key Points
  • Execution of an Underwriting Agreement with Dr AJ Robinson.
  • Underwriting covers up to 1,838,524 unexercised options.
  • Expiry date for option exercise is 29 May 2026.
  • Total funds raised could reach $2,298,155.
  • Funds to support clinical programs in AML and lung cancer.
  • No underwriting fee involved in the agreement.
  • The underwriter is not a related party.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.